Drive implementation of technical solutions and analytical/PAT strategies at the Lilly Medicine Foundry to enable diverse drug substance production, including but not limited to synthetic molecules, bioconjugates, and biologics, leveraging traditional off-line testing in the laboratories or in-line/on-line testing via Process Analytical Technology (PAT) on the production floor. Our current groups include: Africa, Middle East, Central Asia (AMECA), Black Employees at Lilly (BE@Lilly), Chinese Culture Network (CCN), EnAble, Evolve, Lilly Indian Network (LIN), Organization of Latinx at Lilly (OLA), Pride (LGBTQ+ Allies), Veterans Leadership Network (VLN) and Women’s Initiative for Leading at Lilly (WILL).